Related Experiment Video
Updated: Jun 12, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Taking side effects into account for HIV medication.
Vicente Costanza1, Pablo S Rivadeneira, Federico L Biafore
1"Grupo de Sistemas No Lineales", Institutode Desarrollo Tecnológico para la Industria Química, Facultad de Ingeniería Qímica (Universidad Nacional del Litoral, Consejo Nacional de Investigaciones Científicas y Técnicas), 3000 Santa Fe, Argentina. tsinoli@santafe-conicet.gov.ar
IEEE Transactions on Bio-Medical Engineering
|May 27, 2010
Summary
This study introduces a control-theoretic method for designing HIV therapies with fewer side effects. Optimal drug dosing strategies were found to minimize side effects while managing viral load effectively.
Area of Science:
- Control Theory
- Mathematical Biology
- Pharmacology
Background:
- Highly active antiretroviral therapy (HAART) for HIV can cause significant side effects.
- Modeling treatment dynamics is crucial for optimizing drug efficacy and patient safety.
Purpose of the Study:
- To develop a control-theoretic framework for designing HIV therapies with minimized side effects.
- To optimize drug dosage regimens considering viral load and healthy cell dynamics.
Main Methods:
- A control-theoretic approach was used, modeling side effect evolution with a differential equation coupled to HIV dynamics.
- A hybrid dynamic programming scheme integrated discrete-time control with continuous-time state prediction.
- The cost function penalized high viral load and collateral morbidities.
Main Results:
- Optimal strategies suggested lower overall drug usage compared to previous studies.
- High drug doses were recommended at the beginning and end of six-month treatment periods.
- Altering discount rates and penalization influenced dose timing and final viral load, sometimes unacceptably.
Conclusions:
- Control theory offers a viable approach to personalized HIV treatment optimization.
- Careful consideration of cost objectives and discount rates is essential for effective, low-side-effect HIV therapy design.
- The model highlights the trade-offs between minimizing side effects and controlling viral load.
More Related Videos
Related Concept Videos
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...